The serine/threonine kinase Akt (protein kinase B (PKB) 1 ) is a central mediator for many cellular responses involved in cell survival, differentiation, proliferation, and insulin signaling (1, 2). In human there are two major Akt isomers, Akt1 (PKB ␣ ) and Akt2 (PKB ␤ ) (3), which exhibit approximately 80% amino acid sequence identity. Each isomer possesses an N-terminal pleckstrin homology (PH) domain (residues 1-113), a kinase domain (residues 150 -408) that is similar to those found in other AGC members such as cAMP-dependent protein kinase and protein kinase C, and a C-terminal regulatory domain (residues 409 -480) containing a hydrophobic motif (Fig. 1)  (4 -6) . During the activation process, cytosolic Akt is recruited to the plasma membrane through the interaction of its PH domain with phosphatidylinositol 3,4,5-trisphosphate (PIP 3 ), which is generated by phosphatidylinositol 3-kinase in response to the growth factor receptor stimulation. It is thought that the membrane interaction results in conformational changes of Akt, exposing a pair of residues, Thr 308 at the activation loop of the kinase domain and Ser 473 at the hydrophobic motif of the regulatory domain, for phosphorylation by the phosphoinositide-dependent kinase 1 (PDK1) and a putative kinase PDK2, respectively (7-10). It has been demonstrated that the phosphorylation at both Thr 308 and Ser 473 is required for the full activation of Akt (11). The phosphorylated active Akt in turn phosphorylates downstream effectors such as GSK3, PFK2, and BAD (12, 13) .
The serine/threonine kinase Akt (protein kinase B (PKB) 1 ) is a central mediator for many cellular responses involved in cell survival, differentiation, proliferation, and insulin signaling (1, 2) . In human there are two major Akt isomers, Akt1 (PKB ␣ ) and Akt2 (PKB ␤ ) (3), which exhibit approximately 80% amino acid sequence identity. Each isomer possesses an N-terminal pleckstrin homology (PH) domain (residues 1-113), a kinase domain (residues 150 -408) that is similar to those found in other AGC members such as cAMP-dependent protein kinase and protein kinase C, and a C-terminal regulatory domain (residues 409 -480) containing a hydrophobic motif ( Fig. 1 ) (4 -6) . During the activation process, cytosolic Akt is recruited to the plasma membrane through the interaction of its PH domain with phosphatidylinositol 3,4,5-trisphosphate (PIP 3 ), which is generated by phosphatidylinositol 3-kinase in response to the growth factor receptor stimulation. It is thought that the membrane interaction results in conformational changes of Akt, exposing a pair of residues, Thr 308 at the activation loop of the kinase domain and Ser 473 at the hydrophobic motif of the regulatory domain, for phosphorylation by the phosphoinositide-dependent kinase 1 (PDK1) and a putative kinase PDK2, respectively (7) (8) (9) (10) . It has been demonstrated that the phosphorylation at both Thr 308 and Ser 473 is required for the full activation of Akt (11) . The phosphorylated active Akt in turn phosphorylates downstream effectors such as GSK3, PFK2, and BAD (12, 13) .
Structural studies to understand the molecular mechanism for the activation and regulation of Akt have been carried out mostly using x-ray crystallography. To date, high resolution crystal structures of Akt have been reported for the Akt1 PH domain with and without PIP 3 binding (6, 14) , the unliganded inactive Akt2 kinase domain (15) , and the kinase domain of active Akt2 complexed with GSK3␤ peptide and an ATP analog (16) . Studies using NMR or circular dichroism have also provided supportive information on the conformation of Akt bound to PIP 3 (14, 17) . In addition, fluorescence lifetime imaging microscopy has been used to monitor in situ conformational changes in response to growth factor stimulation (18) . Nevertheless up to now these methods demonstrated neither the 3D structure of the whole Akt molecule nor sequential conformational changes involved in the activation process. Apparently an alternative technique to explore the 3D structures of the full-length Akt is required for further understanding of this enzyme. Chemical cross-linking combined with MS has recently emerged as a sensitive tool for probing 3D structure of proteins in solution (19 -23) . Determination of the cross-linked amino acid residues by MS provides spatial distance information that has been proven valuable for the elucidation of protein structural changes due to protein-ligand and protein-protein interactions in more physiologically rele-vant conditions (24 -29) . This approach complements, and sometimes is a viable alternative to, x-ray crystallography, particularly when a whole protein molecule cannot be readily crystallized.
In the present study, we probed the 3D structures of fulllength Akt1 (Akt hereafter) in solution using lysine-specific bifunctional cross-linkers with varying spacer arm lengths and chemistry, including bis(sulfosuccinimidyl) suberate (BS 3 ), disuccinimidyl suberate (DSS), and disuccinimidyl glutarate (DSG), to provide spatial distance constraints between Akt domains yet to be established. To gain insights into the Akt activation mechanism, Akt conformation at different activation stages, including inactive, membrane-interacted, phosphorylated, and substrate-bound states was probed. The crosslinked lysine residues were unambiguously determined by tandem mass spectrometry with static nano-ESI and HPLC/ nano-ESI. 18 O labeling of tryptic digests (30) was used to further confirm the through-space cross-linked peptides (22, 29, 31) and to compare the peak intensity of the cross-linked peptides produced from Akt at various stages of activation. We identified two interdomain cross-linked pairs that allowed us to monitor interdomain conformational changes during activation. These cross-linked pairs also provided spatial distance constraints between domains that are not available from the crystal structure. Our results demonstrate for the first time that Akt undergoes distinctive interdomain conformational changes at each step of activation and substrate binding.
EXPERIMENTAL PROCEDURES
Chemicals-Inactive and phosphorylated active Akt1 with 90% purity was purchased from Upstate Cell Signaling Solutions (Lake Placid, NY) or Calbiochem. BS 3 , DSS, and DSG were purchased from Pierce. Modified trypsin was purchased from Promega (Madison, WI). K-LISA Akt activity kit and adenylyl imidodiphosphate (AMP-PNP) tetralithium salt were purchased from Calbiochem. Phospho-Thr 308 and -Ser 473 Akt antibodies were purchased from Cell Signaling Technology (Beverly, MA). GSK3␤ peptide substrate (GRPRTTSFAE) was purchased from AnaSpec Inc. (San Jose, CA). 1-Palmitoyl-2-oleoylsn-glycero-3-phosphoserine (PS), 1-stearoyl-2-linoleoyl-sn-glycero-3-phosphocholine (PC), and 1-stearoyl-2-oleoyl-sn-glycero-3-phosphoethanolamine (PE) were purchased from Avanti Polar Lipids (Alabaster, AL). L-␣-D-myo-Phosphatidylinositol 3,4,5-trisphosphate was purchased from A. G. Scientific, Inc. (San Diego, CA). HEPES buffer solution was purchased from Invitrogen. Pure water was obtained from a Gemini high purity water system (West Berlin, NJ). H 2 18 O (99%) was purchased from Isotec (Miamisburg, OH). Dimethyl sulfoxide (Me 2 SO) was purchased from Sigma. Other chemicals were purchased from Mallinckrodt.
Cross-linking Reaction and Tryptic Digestion-Akt samples at 5 M were dialyzed overnight against 50 mM HEPES (pH 7.8) containing 50 mM NaCl at 4°C to remove the primary amine-containing Tris-HCl buffer. Aliquots before or after dialysis were used to measure the Akt activity and subjected to Western blotting against phosphospecific Akt antibodies. The Akt activity measured before and after dialysis was identical, although the protein lost ϳ30% of its activity under the conditions used in this study. The samples were incubated with a 50 molar excess of freshly prepared BS 3 (in pH 5.0 sodium citrate), DSS, or DSG (in Me 2 SO at a final concentration of 1% in the reaction mixture) at room temperature for 5 min. At this cross-linking condition intermolecular cross-linked dimers or multimers were not observed according to the SDS-PAGE separation data. The cross-linking reaction was quenched with 1 M Tris-HCl (pH 7.4). The samples were digested with trypsin at 37°C for 20 h using a trypsin to protein ratio of 1:20. Alternatively samples were reduced with dithiothreitol and alkylated with iodoacetamide before tryptic digestion. For 18 O labeling of tryptic digests, samples were dialyzed against water, dried using a vacuum centrifuge, and reconstituted in pure water or 99% H 2 18 O with 5% acetonitrile prior to the digestion with trypsin (29, 31 (32) . After dialysis overnight against 50 mM HEPES (pH 7.8) containing 50 mM NaCl at 4°C, inactive Akt was incubated with the freshly prepared unilamellar vesicles at 37°C for 1 h (33) .
Complex Formation with GSK3␤ Peptide and AMP-PNP-Active or inactive Akt at 5 M was incubated with equivalent volumes of 50 M GSK3␤ peptide substrate and 200 M AMA-PNP (16) at room temperature for 1 h and dialyzed overnight against 50 mM HEPES (pH 7.8) containing 50 mM NaCl at 4°C. After treatment with cross-linkers, aliquots were subjected to tryptic digestion followed by mass spectrometric analysis in accordance with the procedures described under "Cross-linking Reaction and Tryptic Digestion."
Off-line Static Nano-ESI Mass Spectrometric Analysis-Tryptic digests were desalted with a C 18 ZipTip (Millipore Corp.) prior to analysis by a high resolution QSTAR pulsar Qq-TOF mass spectrometer (Applied Biosystems/MDS Sciex, Toronto, CA) equipped with a nanoelectrospray ionization source. The ion source voltage was set at 1100 V in the positive ion mode. A full mass spectrum was acquired over an m/z range of 500 -2000, and the ions of interest were subjected to CID using high purity argon to obtain tandem MS data. The performance of the instrument featured resolution greater than 8000 and mass accuracy with less than 30 ppm error in both full MS and tandem MS mode. The m/z data were reconstructed to generate mass spectra using Analyst QS software (Applied Biosystems/MDS Sciex).
HPLC/Nano-ESI Mass Spectrometric Analysis-HPLC/nano-ESI MS analysis was performed on an Agilent ion trap mass spectrometer (XCT) equipped with an Agilent 1100 nanoflow HPLC system. Peptides were trapped in a C 18 enrichment column (Zorbax 300SB C 18 , 0.3 ϫ 5 mm, Agilent, Wilmington, DE) and then separated on a Zorbax 300SB C 18 column (75 m ϫ 150 mm, 3.5 m) using a mobile phase that contained solvent A (0.1% formic acid in water) and solvent B (0.1% formic acid in acetonitrile) at a flow rate of 300 nl/min. The mobile phase composition was held initially at 3% B for 5 min and gradually changed to 15, 45, and 85% B at 8, 50, 55 min, respectively, and held at 85% for 5 min. The data-dependent automatic scan mode ("Auto-MS 2 ") was used. The capillary voltage was set to 1750 V. The mass spectrometer was scanned from 300 to 2000 m/z range.
Analysis of the Cross-linked Peptides-Protein Analysis Work Sheet (PAWS) was used to assign the mass values of tryptic peptides. The emerging cross-linked peptides were identified by comparing the mass spectra of tryptic peptides obtained from modified sample with those from the unmodified control. Tandem MS data for the crosslinked peptides were manually interpreted with the assistance of Protein Analysis Work Sheet and Analyst QS software (Applied Biosystem/MDS Sciex).
RESULTS AND DISCUSSION

Determination of the Cross-linked Residues in Inactive
Akt-The tryptic peptides of Akt detected by nano-ESI MS represented more than 85% of sequence coverage (Fig. 1) . The cross-linked peptide peaks were distinguished by comparing the static nano-ESI mass spectra obtained from crosslinker-modified Akt with the mass spectrum from the nonmodified control. Fig. 2 shows reconstructed mass spectra of the tryptic digests from the control and modified Akt. Twelve newly emerging peaks were identified in Akt samples modified with DSS. Modification with BS 3 , a hydrophilic analog of DSS, yielded the same results, indicating that all the modified lysine residues are exposed on the surface and easily accessible by both hydrophilic and hydrophobic cross-linking reagents. DSG, which contains a cross-linking arm (C 5 H 6 O 2 ) shorter by (CH 2 ) 3 than that of DSS (C 8 H 12 O 2 ), was used to refine distance constraints for the observed lysine pairs. In the DSG-modified sample, all but one of the newly emerging peaks were observed at mass values 42 Da lower than those observed in the DSS-modified sample. The through-space cross-linked peptide peaks, which are more valuable with respect to protein folding, were further confirmed by 18 O labeling of the tryptic digests. When hydrolyzed in H 2 18 O, each C terminus of a tryptic peptide incorporates two 18 O atoms (30) . Thus, internally cross-linked or end-capped peptides show a 4-Da mass shift, whereas the through-space cross-linking between two peptides results in an 8-Da mass increase (22, 29, 31) . The peptides with masses of 2458, 3465, and 3623 Da, reconstructed from the corresponding multiply charged ions, increased 8 Da in mass when labeled with 18 O, indicating that these peptides resulted from through-space cross-linking. The rest of the emerging peptides showed 4-Da mass shifts indicating that they originated from the end capping or internal cross-linking.
Among the three through-space cross-linked pairs observed in DSS-and BS 3 -modified Akt, the peaks with 2458 and 3465 Da turned out to be interdomain cross-linked peptide pairs according to the MS/MS analysis (Fig. 3) . ) . The sequence assignment was based on the fragment ions observed for both segments and the ions containing C 8 H 10 O 2 . The N-terminal "b" or "a" ions and C-terminal "y" ions from each segment were separately labeled using subscripts ␣ and ␤ (34). The MS/MS analysis also revealed the other interdomain crosslinking between Lys 284 of the kinase domain and Lys 426 of the regulatory domain that was detected at 3465 and 3423 Da after modification with DSS (or BS 3 ) and DSG, respectively (Fig. 2) (Fig. 3, bottom) . Consistently the MS/MS spectra of the corresponding cross-linked peptide detected with mass of 3465 Da in the DSS-or BS 3 -modified samples revealed the same cross-linking with a longer bridge of C 8 H 10 O 2 (data not shown).
Conformational Changes of Akt/PKB during Activation
Probing 3D Structure of Inactive Akt Using Cross-linking Data-Table I summarizes all the cross-linked peptides identified and characterized by tandem MS, including two interdomain and five intradomain cross-linked pairs as well as five end-capped peptides. The presence of all these modified peptide peaks identified by static nano-ESI MS was also unambiguously confirmed by HPLC/MS/MS (data not shown). The ␣-carbon distance constraints for each cross-linked lysine pair determined in the present study are shown in Table I. Table I also lists the ␣-carbon distances between the corresponding lysine residues from the crystal structures of the inactive Akt1 PH domain (Protein Data Bank entry 1unp) or the kinase domain of inactive Akt2 (Protein Data Bank entry 1mrv) as the reference.
Our results indicated that all the cross-linked or endcapped lysine residues were exposed on the surface because they were modified by both hydrophobic DSS and its hydrophilic analog BS 3 . The residues Lys 189 and Lys 268 , which were missing in the crystal structure due to inadequate resolution of the electron density (15) or absence of the equivalent lysine residue, respectively, were also end-capped, revealing that these residues are in the easily accessible environment. The spatial distance constraint generated by DSS (or BS 3 ) or DSG for cross-linked lysine pairs is 24 and 20 Å, respectively, considering the mobility of the side chains of lysine residues (19, 22) . The cross-linking was observed for Lys 30 3 but also with DSG, a shorter cross-linker, indicating that the distance between the ␣-carbons of the lysine residues in each pair is less than 20 Å. This result was in agreement with the x-ray crystallographic data reported for the PH domain of Akt1 and the kinase domain of Akt2. An exception was observed for the interdomain cross-linking between Lys 30 of the PH domain and Lys 389 of the kinase domain that was detected only with the longer cross-linkers DSS and BS 3 but not in the DSGmodified sample, suggesting that the distance between the ␣-carbons of this lysine pair is greater than 20 Å but less than 24 Å. This interdomain distance constraint, which is not yet available from the existing x-ray crystallographic data, should be valuable for modeling a full-length Akt molecule. The presence of the two interdomain cross-linked pairs Lys 30 18 O labeling and/or the intensity comparison using a known unmodified tryptic peptide (data not shown).
To observe the conformational changes upon membrane interaction, inactive Akt was incubated with liposomes containing PE/PC/PS/PIP 3 at a ratio of 50:18:30:2, which approximated a lipid composition in the inner leaflet of the neuronal plasma membrane under a stimulated condition, considering the fact that PS is exclusively localized in the inner plasma membrane, whereas PC is mostly on the outside. Under this condition, the two interdomain cross-linked pairs Lys (Fig. 5, top) . Because individual modification of these lysine residues was observed under this condition (data not shown), it is clear that these residues were still accessible, suggesting that the cross-linking partners in Lys (Fig. 5, bottom) , indicating that the spatial distance between Lys 30 and Lys 389 remained 20 -24 Å as was the case with the inactive Akt. An analytical concern regarding the conclusion drawn from the comparison of peak abundance between non-identical complex mixtures is that peaks of interest may be reduced or eliminated due to ion suppression in different samples. To undoubtedly confirm the observed changes of the peaks, we took advantage of the 18 O labeling technique. The crosslinker-modified inactive Akt sample digested in H 2 18 O was mixed with the modified Akt samples from different activation stages digested in normal H 2 16 O water, and the mixture was subjected to MS analysis. As an example, the mass spectrum is shown in Fig. 6 for the DSS-modified 18 O-labeled digest of the inactive Akt mixed with the 16 O digest of the DSS-modified active Akt at a ratio of 1:1. As expected the peak intensity ratio of the non-cross-linked tryptic peptide with mass of (␣H/␣I loop), remained unaltered after membrane interaction, phosphorylation, or substrate binding. Although the local conformational changes within each domain could not be probed by this approach due to the low resolution in probing distance constraints using current cross-linkers, the changes in the interdomain cross-linking observed in this study clearly indicated that arrangements of individual domains were profoundly affected during activation processes.
Proposed Scheme for Interdomain Conformational Changes in Akt Activation-From the currently available biochemical data (1, 5) it has been proposed that PIP 3 interacts with the PH domain of Akt, exposing Thr 308 and Ser
473
, which in turn are subjected to phosphorylation by upstream kinases for activation (1, 7). For example, mutating the PH domain abolishes the phosphorylation and activation of Akt by the upstream kinases even in the presence of PIP 3 (7) . On the other hand, truncation of the PH domain results in phosphorylation and activation of Akt without PIP 3 (7) . These data suggest that the PH domain may block the access of the upstream kinase to the phosphorylation sites of Akt, and the binding of PIP 3 to the PH domain is a way to remove such structural hindrance. Additionally an in situ study using fluorescence lifetime imaging microscopy has suggested that Akt undergoes a conformational change at the plasma membrane upon growth factor stimulation in intact cells (18) . Nevertheless no structural evidence is available concerning the alteration of interdomain arrangements accompanying the activation sequence. 284 and Lys 426 moved farther away from each other during activation, at least by 16 Å, considering the reported distance between the corresponding residues (7.8 Å) from the crystal structure of inactive Akt2 (Table I ). The crystal structure has revealed that the binding pockets for the substrate peptide and ATP, located within the activation loop and at the interface between the N-lobe (containing ␤1-5, ␣B, and ␣C) and C-lobe (mainly an ␣-helix), respectively, are blocked in the inactive Akt2 molecule (15, 16) with the C-terminal chain covering part of the ATP binding site. In addition, it has been suggested that residues such as Phe 439 of the regulatory domain assist stabilization of the blocking conformation (15) , and a dramatic conformational change to unblock these binding sites is required for Akt activation (15, 16) . According to our data such dramatic displacement of the regulatory domain was introduced by the interaction with membrane, uncovering the binding pockets, and this open conformation was sustained after phosphorylation. Most probably, this open conformation allows substrate entry to the kinase domain, serving as an important determinant for the activated state of Akt in cytosol. The presence of cross-linked pair Lys 284 -Lys 426 after binding to GSK3␤ peptide and AMP-PNP suggests that a closed conformation was reestablished upon substrate binding. Although it is not easily explicable how peptide binding changes the conformation so dramatically, this result appeared to be in agreement with the crystal structure of Akt2, which was activated by Thr 309 phosphorylation and S474D mutation and complexed with GSK3␤ peptide and AMP-PNP, where the distance between Lys 285 and Lys 427 was indicated to be 7.0 Å (Protein Data Bank entry 1o6k) (11) .
In summary, our results strongly suggest that Akt undergoes distinctive conformational changes at each step of activation sequence. Based on our data, the following activation scheme is proposed (Fig. 7) . Inactive Akt exists with a folded structure in cytoplasm with the PH and regulatory domains covering the kinase domain at least in part. Membrane translocation causes conformational changes of Akt so that both PH and regulatory domains become separated from the kinase domain to expose Thr 308 and Ser 473 for phosphorylation. Phosphorylation of Akt presumably triggers the separation of the PH domain from membrane, releasing Akt to the cytoplasm. The open conformation of the regulatory domain in the activated form of cytosolic Akt allows substrate entry, which is an important determinant for the activated state of Akt. This model is consistent with the well accepted notion that Akt activity correlates with conformational changes allowing phosphorylation at Thr 308 and Ser 473 (1, 5 ). Furthermore our model may offer an explanation for the previous findings that Ser 474 phosphorylation is required for full activation of Akt2 (11) by depicting the regulatory domain moved away from the kinase domain after phosphorylation, allowing facilitated substrate entry and enhancing overall activity.
In conclusion, our results provide the first demonstration for the dramatic interdomain conformational changes in the fulllength Akt structure in solution during activation and substrate binding. Our results also provide valuable complementary information to the crystal structures of this molecule. More importantly, our results set up a stage for the further investigation on FIG. 7 . Schematic model for interdomain conformational changes accompanying Akt activation and substrate binding. In cytosol, inactive Akt exists as a folded molecule with the PH and regulatory domains covering parts of the kinase domain. Akt is recruited to the plasma membrane through the interaction of its PH domain with PIP 3 . The membrane interaction results in a conformational change, moving the PH and regulatory domains away from the kinase domain and exposing Thr 308 and Ser 473 for phosphorylation by upstream kinases. When Akt is activated by phosphorylation at both sites, the PH domain closes, possibly enabling the separation of Akt from the membrane. The regulatory domain, which remained open, allows the substrate entry, and upon substrate binding the regulatory domain returns to a closed conformation as in the inactive form. PIP2, phosphatidylinositol 4,5-bisphosphate; PI3K, phosphatidylinositol 3-kinase; pS, phosphoserine; pT, phosphothreonine.
